Ischemic stroke
Pro Research Analysisby 
Searched over 200M research papers for "ischemic stroke"
Ischemic Stroke: Global Burden and Risk Factors
Ischemic stroke is a leading cause of death and long-term disability worldwide, accounting for about 75–80% of all stroke cases. The global number of deaths from ischemic stroke has risen significantly, from 2.04 million in 1990 to 3.29 million in 2019, and is projected to reach 4.90 million by 2030. The burden is especially high in low socio-demographic index regions and among younger populations. Major risk factors include behavioral factors like smoking and high-sodium diets, as well as metabolic factors such as high blood pressure, high LDL cholesterol, kidney dysfunction, high fasting plasma glucose, and high body mass index. Effective control of these risk factors is crucial for reducing the global impact of ischemic stroke .
Pathophysiology and Molecular Mechanisms of Ischemic Stroke
Ischemic stroke occurs when a cerebral blood vessel is blocked, leading to reduced blood flow and subsequent brain tissue damage. The extent of injury depends on factors such as the duration and severity of ischemia, collateral blood flow, patient age, comorbidities, and genetic background. The pathophysiology involves a complex interplay of cellular excitotoxicity, oxidative stress, various forms of cell death (including apoptosis, necroptosis, ferroptosis, and others), and neuroinflammation. Multiple signaling pathways are implicated, and targeting these pathways offers potential for new therapeutic interventions 4610.
Immune and Inflammatory Responses in Ischemic Stroke
The immune response following ischemic stroke plays a dual role, contributing both to neuronal injury and tissue repair. Glial cells, such as microglia, astrocytes, and oligodendrocytes, are central to this process. Activated microglia can release inflammatory cytokines that worsen injury, but they can also secrete anti-inflammatory factors that aid recovery. Astrocytes help limit brain injury and restore homeostasis, though glial scarring can impede neuronal repair. Oligodendrocyte responses influence demyelination and remyelination, affecting functional recovery. Understanding these immune mechanisms is key to developing new treatment strategies 79.
Advances in Diagnosis and Acute Management
Early recognition and rapid treatment are critical for improving outcomes in acute ischemic stroke. The use of emergency medical services and specialized stroke centers has been shown to reduce morbidity and mortality. Intravenous thrombolysis with alteplase within 4.5 hours of symptom onset and early aspirin administration are established treatments. Advanced imaging techniques help identify patients who may benefit from endovascular thrombectomy, even in extended time windows. Close monitoring in dedicated stroke units and early intervention for complications are essential components of care 125.
Experimental Models and Translational Research
Animal models, particularly those involving occlusion of the middle cerebral artery in rodents, are widely used to study ischemic stroke. These models help researchers understand the molecular and cellular events following stroke and test potential therapies. However, the complexity and variability of human stroke are challenging to replicate fully in experimental settings, highlighting the need for continued translational research .
Emerging Therapeutic Targets and Future Directions
Current treatments focus on rapid reperfusion, but there is a growing interest in neuroprotective strategies that target the molecular and immune pathways involved in ischemic injury. The Nrf2 pathway, which regulates antioxidant responses, is one promising target for reducing oxidative damage. Ongoing research aims to bridge the gap between basic science and clinical application, with the goal of developing new interventions that can further reduce the burden of ischemic stroke 4810.
Conclusion
Ischemic stroke remains a major global health challenge, with rising incidence and significant disability. Advances in acute management, better understanding of risk factors, and insights into molecular and immune mechanisms are shaping new strategies for prevention and treatment. Continued research and targeted interventions are essential to reduce the impact of ischemic stroke worldwide 1234+6 MORE.
Sources and full results
Most relevant research papers on this topic